DCM Shriram Consolidated LTD (DSCL) was one of the companies that emerged when the erstwhile DCM LTD was split in 1989. Ajay Shriram and Vikram Shriram inherited the company. They are the sons of Shashi Dhar and great-grandsons of founder Lala Shrira... More
The Indian arm of 3M Company entered India with a tie-up with the Birlas in 1987. Today it sells about 6,000 products across segments like industrial and transportation; health care; safety, security and protection services; consumer and office and d... More
DCM SHRIRAM | 3M INDIA | DCM SHRIRAM/ 3M INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 11.7 | 121.8 | 9.6% | View Chart |
P/BV | x | 2.2 | 16.1 | 13.4% | View Chart |
Dividend Yield | % | 2.1 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DCM SHRIRAM Mar-19 |
3M INDIA Mar-19 |
DCM SHRIRAM/ 3M INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 500 | 26,679 | 1.9% | |
Low | Rs | 223 | 18,214 | 1.2% | |
Sales per share (Unadj.) | Rs | 498.3 | 2,676.9 | 18.6% | |
Earnings per share (Unadj.) | Rs | 57.9 | 304.5 | 19.0% | |
Cash flow per share (Unadj.) | Rs | 68.0 | 343.3 | 19.8% | |
Dividends per share (Unadj.) | Rs | 9.80 | 0 | - | |
Dividend yield (eoy) | % | 2.7 | 0 | - | |
Book value per share (Unadj.) | Rs | 226.1 | 1,271.4 | 17.8% | |
Shares outstanding (eoy) | m | 155.94 | 11.27 | 1,383.7% | |
Bonus/Rights/Conversions | BB | - | - | ||
Price / Sales ratio | x | 0.7 | 8.4 | 8.6% | |
Avg P/E ratio | x | 6.2 | 73.7 | 8.5% | |
P/CF ratio (eoy) | x | 5.3 | 65.4 | 8.1% | |
Price / Book Value ratio | x | 1.6 | 17.7 | 9.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 56,341 | 252,972 | 22.3% | |
No. of employees | `000 | 5.4 | 1.4 | 390.8% | |
Total wages/salary | Rs m | 6,637 | 3,302 | 201.0% | |
Avg. sales/employee | Rs Th | 14,439.1 | 21,908.6 | 65.9% | |
Avg. wages/employee | Rs Th | 1,233.2 | 2,398.0 | 51.4% | |
Avg. net profit/employee | Rs Th | 1,677.1 | 2,492.0 | 67.3% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 77,711 | 30,168 | 257.6% | |
Other income | Rs m | 876 | 368 | 238.0% | |
Total revenues | Rs m | 78,588 | 30,537 | 257.4% | |
Gross profit | Rs m | 13,687 | 5,356 | 255.5% | |
Depreciation | Rs m | 1,572 | 438 | 359.1% | |
Interest | Rs m | 1,189 | 11 | 10,619.6% | |
Profit before tax | Rs m | 11,802 | 5,275 | 223.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2,776 | 1,844 | 150.6% | |
Profit after tax | Rs m | 9,026 | 3,432 | 263.0% | |
Gross profit margin | % | 17.6 | 17.8 | 99.2% | |
Effective tax rate | % | 23.5 | 35.0 | 67.3% | |
Net profit margin | % | 11.6 | 11.4 | 102.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 37,579 | 16,568 | 226.8% | |
Current liabilities | Rs m | 24,136 | 6,490 | 371.9% | |
Net working cap to sales | % | 17.3 | 33.4 | 51.8% | |
Current ratio | x | 1.6 | 2.6 | 61.0% | |
Inventory Days | Days | 90 | 50 | 181.7% | |
Debtors Days | Days | 49 | 71 | 68.8% | |
Net fixed assets | Rs m | 30,220 | 2,984 | 1,012.6% | |
Share capital | Rs m | 314 | 113 | 278.2% | |
"Free" reserves | Rs m | 34,943 | 14,216 | 245.8% | |
Net worth | Rs m | 35,257 | 14,328 | 246.1% | |
Long term debt | Rs m | 9,368 | 76 | 12,310.5% | |
Total assets | Rs m | 71,364 | 21,183 | 336.9% | |
Interest coverage | x | 10.9 | 472.0 | 2.3% | |
Debt to equity ratio | x | 0.3 | 0 | 5,003.0% | |
Sales to assets ratio | x | 1.1 | 1.4 | 76.5% | |
Return on assets | % | 14.3 | 16.3 | 88.1% | |
Return on equity | % | 25.6 | 23.9 | 106.9% | |
Return on capital | % | 29.1 | 36.7 | 79.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 1,113 | 1,038 | 107.2% | |
Fx outflow | Rs m | 3,887 | 11,778 | 33.0% | |
Net fx | Rs m | -2,775 | -10,740 | 25.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 7,749 | 2,530 | 306.3% | |
From Investments | Rs m | -8,034 | -5,534 | 145.2% | |
From Financial Activity | Rs m | 2,769 | 32 | 8,544.8% | |
Net Cashflow | Rs m | 2,483 | -2,972 | -83.6% |
Indian Promoters | % | 63.9 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 75.0 | - | |
Indian inst/Mut Fund | % | 10.7 | 3.8 | 281.6% | |
FIIs | % | 1.7 | 9.3 | 18.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 23.7 | 11.9 | 199.2% | |
Shareholders | 43,249 | 9,225 | 468.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare DCM SHRIRAM With: DELTA CORP GMR INFRA RELIANCE CAPITAL MAX FINANCIAL SERVICES EVEREADY INDUSTRIES
Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.
For the quarter ended December 2020, DCM SHRIRAM has posted a net profit of Rs 3 bn (up 44.2% YoY). Sales on the other hand came in at Rs 21 bn (down 2.6% YoY). Read on for a complete analysis of DCM SHRIRAM's quarterly results.
For the quarter ended June 2020, 3M INDIA has posted a net profit of Rs 425 m (down 147.2% YoY). Sales on the other hand came in at Rs 3 bn (down 57.0% YoY). Read on for a complete analysis of 3M INDIA's quarterly results.
For the quarter ended June 2020, DCM SHRIRAM has posted a net profit of Rs 701 m (down 68.2% YoY). Sales on the other hand came in at Rs 19 bn (up 0.5% YoY). Read on for a complete analysis of DCM SHRIRAM's quarterly results.
For the quarter ended March 2020, DCM SHRIRAM has posted a net profit of Rs 2 bn (down 29.0% YoY). Sales on the other hand came in at Rs 19 bn (up 1.6% YoY). Read on for a complete analysis of DCM SHRIRAM's quarterly results.
For the quarter ended March 2020, 3M INDIA has posted a net profit of Rs 601 m (down 0.3% YoY). Sales on the other hand came in at Rs 7 bn (down 9.4% YoY). Read on for a complete analysis of 3M INDIA's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More